Tag
2 articles
GSK and Relation Therapeutics have formed a $110 million collaboration to generate large-scale biological datasets for AI drug discovery, emphasizing the critical role of high-quality data in advancing AI models.
Relation Therapeutics is tackling the data scarcity issue in AI-driven biology by manufacturing the datasets needed to train AI models of the cell. GSK has committed up to $110 million to support this effort.